SCHEMBL8303472

SCHEMBL8303472

NC(=O)c1ccc(N2CCCNC2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 1/20 0.49
BCAT2 O15382 1/20 0.47
ALDH1A1 P00352 4/20 0.45
F10 P00742 3/20 0.44
KLK5 Q9Y337 1/20 0.44
HPGD P15428 3/20 0.40
F2 P00734 1/20 0.40
PRSS1 P07477 1/20 0.40
EIF2AK2 P19525 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA10 Q9GZZ6 1/20 0.39
CHRNA9 Q9UGM1 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
CMA1 P23946 1/20 0.39
ACVR1 Q04771 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692282 0.85 ALDH1A1 (0.63) ALDH1A1F10HPGDEIF2AK2POLB
SCHEMBL14491992 0.81 DDB1 (0.53) ALDH1A1F10SMN1; SMN2NPC1POLB
SCHEMBL4744986 0.80 ALDH1A1 (0.48) ALDH1A1F10HPGDSMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL5314439 0.80 DDB1 (0.51) ALDH1A1F10SMN1; SMN2NPC1POLB
SCHEMBL14686809 0.77 HTT (0.52) ALDH1A1HPGDSMN1; SMN2NPC1MAPT
SCHEMBL4418893 0.77 ALDH1A1 (0.75) BCAT2ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL25680366 0.77 EIF2AK2 (0.46) BCAT2ALDH1A1F10HPGDEIF2AK2
SCHEMBL8286230 0.76 SMN1; SMN2 (0.54) ALDH1A1HPGDF2SMN1; SMN2NPC1
SCHEMBL6324186 0.76 RXFP1 (0.40) ALDH1A1F10HPGDSMN1; SMN2POLB
SCHEMBL1259982 0.76 ALDH1A1 (0.46) ALDH1A1HPGDNPC1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed